Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus

Medical Mycology

Volumn 47, Issue SUPPL. 1, 2009, Pages

  Pasqualotto, Alessandro C ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; ALBUMIN; AMPHOTERICIN B; ASPERGILLUS TOXIN; CALCINEURIN; ELASTASE; ELASTIN; FIBRONECTIN; FUMAGILLIN; GLIOTOXIN; HELVOLIC ACID; LAMININ; MELANIN; MYCOTOXIN; PROTEINASE; UNCLASSIFIED DRUG; VORICONAZOLE;

ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; BRONCHOPULMONARY ASPERGILLOMA; CELL ADHESION; CELL INTERACTION; CELL SURFACE; CHRONIC CAVITARY PULMONARY ASPERGILLOSIS; CLINICAL TRIAL; CONIDIUM; ENDOTHELIUM CELL; FUNGAL METABOLISM; FUNGAL SINUSITIS; FUNGAL SPORE GERMINATION; FUNGAL VIRULENCE; FUNGUS CELL INTERACTION; FUNGUS IDENTIFICATION; GEOGRAPHICAL VARIATION (SPECIES); HEAT TOLERANCE; HOST SUSCEPTIBILITY; HUMAN; INVASIVE ASPERGILLOSIS; KERATITIS; LUNG ALVEOLUS EPITHELIUM; LUNG INFECTION; MYCOSIS; NONHUMAN; ORGANISMS BY SIZE; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PROTEIN FUNCTION; REVIEW; SKIN INFECTION; SPECIES DIFFERENCE; UPPER RESPIRATORY TRACT; WOUND INFECTION; ANIMAL; COMPARATIVE STUDY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY;

ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; HUMANS;

EID: 67651096196     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802247702     Document Type: Review

References (100)

1. Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning DW. Aspergillus flavus: Human pathogen, allergen and mycotoxin producer. Microbiology 2007; 153: 1677-1692.
2. Moubasher AH, Abdel-Fattah HM, Swelim MA, Studies on airborne fungi at Qena. I. Seasonal fluctuations. Z Allg Mikrobiol 1981; 21: 247-253.
3. Abdalla MH. Prevalence of airborne Aspergillus flavus in Khartoum (Sudan) airspora with reference to dusty weather and inoculum survival in simulated summer conditions. Mycopathologia 1988; 104: 137-141.
4. Gupta SK, Pereira BM, Singh AB. Survey of airborne culturable and non-culturable fungi at different sites in Delhi metropolis. Asian Pac J Allergy Immunol 1993; 11: 19-28.
5. Adhikari A, Sen MM, Gupta-Bhattacharya S, Chanda S. Airborne viable, non-viable, and allergenic fungi in a rural agricultural area of India: a 2-year study at five outdoor sampling stations. Sci Total Environ 2004; 326: 123-141.
6. Khairallah SH, Byrne KA, Tabbara KF. Fungal keratitis in Saudi Arabia. Doc Ophthalmol 1992; 79: 269-276.
7. Kameswaran M, al-Wadei A, Khurana P, Okafor BC. Rhinocerebral aspergillosis. J Laryngol Otol 1992; 106: 981-985.
8. Mahgoub ES, el-Hassan AM. Pulmonary aspergillosis caused by Aspergillus flavus. Thorax 1972; 27: 33-37.
9. Calvo A, Guarro J, Suarez G, Ramirez C, Air-borne fungi in the air of Barcelona (Spain). III. The genus Aspergillus Link. Mycopathologia 1980; 71: 41-43.
10. Guinea J, Peláez T, Alcalá L, Bouza E. Outdoor environmental levels of Aspergillus spp. conidia over a wide geographical area. Med Mycol 2006; 44: 349-356.
11. Mallea M, Murray IG, Segretain G, et al. Census of Aspergillus colonies in the air comparison between London, Paris, Lyon, Marseilles. Acta Allergol 1972; 27: 273-278.
12. Hohl TM, Feldmesser M. Aspergillus fumigatus: Principles of pathogenesis and host defense. Eukaryot Cell 2007; 6: 1953-1963.
13. Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-350.
14. Latgé JP. The pathobiology of Aspergillus fumigatus. Trends Microbiol 2001; 9: 382-389.
15. Girardin H, Paris S, Rault J, Bellon-Fontaine MN, Latgé JP. The role of the rodlet structure on the physicochemical properties of Aspergillus conidia. Lett Appl Microbiol 1999; 29: 364-369.
16. Paris S, Debeaupuis JP, Crameri R, et al. Conidial hydrophobins of Aspergillus fumigatus. Appl Environ Microbiol 2003; 69 1581-1588.
17. Thau N, Monod M, Crestani B, et al. Rodletless mutants of Aspergillus fumigatus. Infect Immun 1994; 62: 4380-4388.
18. Langfelder K, Streibel M, Jahn B, Haase G, Brakhage AA. Biosynthesis of fungal melanins and their importance for human pathogenic fungi. Fungal Genet Biol 2003; 38: 143-158.
19. Brakhage AA, Liebmann B. Aspergillus fumigatus conidial pigment and cAMP signal transduction, significance for virulence. Med Mycol 2005; 43 (Suppl 1): 75-82.
20. Casadevall A, Rosas AL, Nosanchuk JD. Melanin and virulence in Cryptococcus neoformans. Curr Opin Microbiol 2000; 3: 354-358.
21. Romero-Martinez R, Wheeler M, Guerrero-Plata A, Rico G, Torres-Guerrero H. Biosynthesis and functions of melanin in Sporothrix schenckii. Infect Immun 2000; 68: 3696-3703.
22. Morris-Jones R, Youngchim S, Gómez BL, et al. Synthesis of melanin-like pigment by Sporothrix schenckii in vitro and during mammalian infection. Infect Immun 2003; 71: 4026-4033.
23. Jahn B, Koch A, Schmidt A, et al. Isolation and characterization of a pigmentless conidium mutant of Aspergillus fumigatus with altered conidia surface and reduced virulence. Infect Immun 1997; 65: 5110-5117.
24. Tsai HF, Chang YC, Washburn RG, Wheeler MH, Kwon-Chung KJ. The developmentally regulated alb1 gene of Aspergillus fumigatus: Its role in modulation of conidial morphology and virulence. J Bacteriol 1998; 180: 3031-3038.
25. Tsai HF, Wheeler MH, Chang YC, Kwon-Chung KJ. A developmentally regulated gene cluster involved in conidial pigment biosynthesis in Aspergillus fumigatus. J Bacteriol 1999; 181: 6469-6477.
26. Youngchim S, Morris-Jones R, Hay RJ, Hamilton AJ. Production of melanin by Aspergillus fumigatus. J Med Microbiol 2004; 53: 175-181.
27. Penalver MC, O'Connor JE, Martinez JP, Gil ML. Binding of human fibronectin to Aspergillus fumigatus conidia. Infect Immun 1996; 64: 1146-1153.
28. Bromley IM, Donaldson K. Binding of Aspergillus fumigatus spores to lung epithelial cells and basement membrane proteins: Relevance to the asthmatic lung. Thorax 1996; 51: 1203-1209.
29. Gil ML, Penalver MC, Lopez-Ribot JL, O'Connor JE, Martinez JP. Binding of extracellular matrix proteins to Aspergillus fumigatus conidia. Infect Immun 1996; 64: 5239-5247.
30. Tronchin G, Bouchara JP, Larcher G, Lissitzky JC, Chabasse D. Interaction between Aspergillus fumigatus and basement membrane laminin: Binding and substrate degradation. Biol Cell 1993; 77 201-208.
31. Bouchara J-P, Bouali A, Tronchin G, et al. Binding of fibrinogen to the pathogenic Aspergillus species. J Med Vet Mycol 1988; 26: 327-34.
32. Wasylnka JA, Moore MM. Adhesion of Aspergillus species to extracellular matrix proteins: Evidence for involvement of negatively charged carbohydrates on the conidial surface. Infect Immun 2000; 68: 3377-3384.
33. Dubourdeau M, Athman R, Balloy V, et al. Interaction of Aspergillus fumigatus with the alveolar macrophage. Med Mycol 2006; 44 (Suppl. 1): 213-217.
34. Roilides E, Sein T, Holmes A, et al. Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Infect Dis 1995; 172: 1028-1034.
35. Jahn B, Rampp A, Dick C, et al. Accumulation of amphotericin B in human macrophages enhances activity against Aspergillus fumigatus conidia: Quantification of conidia kill at the single-cell level. Antimicrob Agents Chemother 1998; 2: 2569-2575.
36. Akpogheneta O, Gil-Lamaignere C, Maloukou A, Roilides E. Antifungal activity of human polymorphonuclear and mononuclear phagocytes against non-fumigatus Aspergillus species. Mycoses 2003; 46: 77-83.
37. Perkhofer S, Speth C, Dierich MP, Lass-Flörl C. In vitro determination of phagocytosis and intracellular killing of Aspergillus species by mononuclear phagocytes. Mycopathologia 2007; 163: 303-307.
38. Araujo R, Rodrigues AG. Variability of germinative potential among pathogenic species of Aspergillus. J Clin Microbiol 2004; 42: 4335-4337.
39. Manavathu EK, Cutright J, Chandrasekar OH. Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents. J Clin Microbiol 1999; 37: 858-861.
40. Fedorova ND, Khaldi N, Joardar VS, et al. Genomic islands in the pathogenic filamentous fungus Aspergillus fumigatus. PLoS Genet 2008; 4: E1000046.
41. Lopes-Bezerra LM, Filler SG. Interactions of Aspergillus fumigatus with endothelial cells: Internalization, injury, and stimulation of tissue factor activity. Blood 2004; 103 : 2143-2149.
42. Rodrigues AG, Araujo R, Pina-Vaz C. Human albumin promotes germination, hyphal growth and antifungal resistance by Aspergillus fumigatus. Med Mycol 2005; 43: 711-717.
43. Cox GM, McDade HC, Chen SC, et al. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 2001; 39: 166-175.
44. Shibuya K, Paris S, Ando T, et al. Catalases of Aspergillus fumigatus and inflammation in aspergillosis. Jpn J Med Mycol 2006; 47: 249-255.
45. Mellon JE, Cotty PJ, Dowd MK. Aspergillus flavus hydrolases: Their roles in pathogenesis and substrate utilization. Appl Microbiol Biotechnol 2007; 77: 497-504.
46. Tomee JF, Kauffman HF. Putative virulence factors of Aspergillus fumigatus. Clin Exp Allergy 2000; 30: 476-484.
47. Kothary MH, Chase T, MacMillan JD. Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infect Immun 1984; 43 320-325.
48. Rhodes JC. Aspergillus proteinases and their interactions with host tissues. Can J Bot 1995; 73 (Suppl. 1E-H): S1126-1131.
49. Kolattukudy PE, Lee JD, Rogers LM, et al. Evidence for possible involvement of an elastolytic serine protease in aspergillosis. Infect Immun 1993; 61: 2357-2368.
50. Ibrahim-Granet O, Dubourdeau M, Latgé JP, et al. Methylcitrate synthase from Aspergillus fumigatus is essential for manifestation of invasive aspergillosis. Cell Microbiol 2008; 10: 134-148.
51. Reichard U, Büttner S, Eiffert H, Staib F, Rüchel R. Purification and characterisation of an extracellular serine proteinase from Aspergillus fumigatus and its detection in tissue. J Med Microbiol 1990; 33: 243-251.
52. Reichard U, Monod M, Odds F, Rüchel R. Virulence of an aspergillopepsin-deficient mutant of Aspergillus fumigatus and evidence for another aspartic proteinase linked to the fungal cell wall. J Med Vet Myco 1997; 35: 189-196.
53. Monod M, Paris S, Sarfati J, et al. Virulence of alkaline proteasedeficient mutants of Aspergillus fumigatus. FEMS Microbiol Lett 1993; 106: 39-46.
54. Monod M, Paris S, Sanglard D, et al. Isolation and characterization of a secreted metalloprotease of Aspergillus fumigatus. Infect Immun 1993; 61: 4099-4104.
55. Tang CM, Cohen J, Krausz T, Van Noorden S, Holden DW. The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect Immun 1993; 61: 1650-1656.
56. Jaton-Ogay K, Paris S, Huerre M, et al. Cloning and disruption of the gene encoding an extracellular metalloprotease of Aspergillus fumigatus. Mol Microbiol 1994; 14: 917-928.
57. Smith JM, Tang CM, Van Noorden S, Holden DW. Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Infect Immun 1994; 62: 5247-5254.
58. Reichard U, Lechenne B, Asif AR, et al. Sedolisins, a new class of secreted proteases from Aspergillus fumigatus with endoprotease or tripeptidyl-peptidase activity at acidic pHs. Appl Environ Microbiol 2006; 72: 1739-1748.
59. Fleck CB, Brock M. Characterization of an acyl-CoA: Carboxylate CoA-transferase from Aspergillus nidulans involved in propionyl-CoA detoxification. Mol Microbiol 2008; 68: 642-656.
60. Monod M, Capoccia S, Léchenne B, et al. Secreted proteases from pathogenic fungi. Int J Med Microbiol 2002; 292: 405-419.
61. Cusumano V, Costa GB, Seminara S. Effect of a-atoxins on rat peritoneal macrophages. Appl Environ Microbiol 1990; 11: 3482-3484.
62. Ford S, Friedman L. Experimental study of the pathogenicity of aspergilli for mice. J Bacteriol 1967; 94: 928-33.
63. Richard JL, Thurston JR, Peden WM, Pinello C. Recent studies on aspergillosis in turkey poults. Mycopathologia 1984; 87: 3-11.
64. Kupfahl C, Michalka A, Lass-Flörl C, et al. Gliotoxin production by clinical and environmental Aspergillus fumigatus strains. Int J Med Microbiol 2007; 298: 319-327.
65. Amitani R, Taylor G, Elezis EM, et al. Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun 1995; 63: 3266-3271.
66. Lewis RE, Wiederhold NP, Chi J, et al. Detection of gliotoxin in experimental and human aspergillosis. Infect Immun 2005; 73: 635-637.
67. Sutton P, Newcombe NR, Waring P, Müllbacher A. In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect Immun 1994; 62: 1192-1198.
68. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34: 7-14.
69. Lewis RE, Wiederhold NP, Lionakis MS, Prince RA, Kontoyiannis DP. Frequency and species distribution of gliotoxinproducing Aspergillus isolates recovered from patients at a tertiary-care cancer center. J Clin Microbiol 2005; 43: 6120-6122.
70. Liu J, Farmer JD Jr, Lane WS, et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991; 66: 807-815.
71. Steinbach WJ, Cramer RA Jr, Perfect BZ, et al. Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryot Cell 2006; 5: 1091-1103.
72. Goldman GH, Ferreira ME, Semighini CP, Harris SD, Fedorova ND. Deletion of the Aspergillus fumigatus calcineurin gene decreases virulence in a low dose murine infection. In: 2nd Advances Against Aspergillosis. Athens, Greece, 2006: Presentation O-2.
73. Steinbach WJ, Schell WA, Blankenship JR, et al. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Antimicrob Agents Chemother 2004; 48 1664-1669.
74. Nobre G. Sensitivity to 5-fluorocytosine and virulence for mice of some human isolates of Aspergillus. Mycopathologia 1977; 62 57-60.
75. Mosquera J,Warn PA,Morrissey J, et al. Susceptibility testing of Aspergillus flavus: Inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo. Antimicrob Agents Chemother 2001; 45: 1456-1462.
76. Denning DW, Radford SA, Oakley KL, et al. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother 1997; 40: 401-414.
77. Johnson EM, Oakley KL, Radford SA, et al. Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J Antimicrob Chemother 2000; 45: 85-93.
78. Chakrabarti A, Jatana M, Sharma SC. Rabbit as an animal model of paranasal sinus mycoses. J Med Vet Mycol 1997; 35: 295-297.
79. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-15.
80. Cornely OA, Maertens J, Bresnik M, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis 2007; 44: 1289-1297.
81. Sandison AT, Gentles JC, Davidson CM, Branko M. Aspergilloma of paranasal sinuses and orbit in northern Sudanese. Sabouraudia 1967; 6: 57-69.
82. Milosev B, el-Mahgoub S, Aal OA, el-Hassan AM. Primary aspergilloma of paranasal sinuses in the Sudan: A review of seventeen cases. Br J Surg 1969; 56: 132-137.
83. Mukherji SK, Figueroa RE, Ginsberg LE, et al. Allergic fungal sinusitis: CT findings. Radiology 1998; 207: 417-422.
84. Taj-Aldeen SJ, Hilal AA, Schell WA. Allergic fungal rhinosinusitis: A report of 8 cases. Am J Otolaryngol 2004; 25: 213-218.
85. Taj-Aldeen SJ, Hilal AA, Chong-Lopez A. Allergic Aspergillus flavus rhinosinusitis: A case report from Qatar. Eur Arch Otorhinolaryngol 2003; 260: 331-335.
86. Saravanan K, Panda NK, Chakrabarti A, Das A, Bapuraj RJ. Allergic fungal rhinosinusitis: An attempt to resolve the diagnostic dilemma. Arch Otolaryngol Head Neck Surg 2006; 132: 173-178.
87. Chhabra A, Handa KK, Chakrabarti A, Mann SB, Panda N. Allergic fungal sinusitis: Clinicopathological characteristics. Mycoses 1996; 39: 437-441.
88. Fadl FA, Hassan KM, Faizuddin M. Allergic fungal rhinosinusitis: Report of 4 cases from Saudi Arabia. Saudi Med J 2000; 21: 581-584.
89. Khan ZU, Sandhu RS, Randhawa HS, Menon MP, Dusaj IS. Allergic bronchopulmonary aspergillosis: A study of 46 cases with special reference to laboratory aspects. Scand J Respir Dis 1976; 57 73-87.
90. Sandhu RS, Mehta SK, Khan ZU, Singh MM. Role of Aspergillus and Candida species in allergic bronchopulmonary mycoses. A comparative study. Scand J Respir Dis 1979; 60: 235-242.
91. Chakrabarti A, Sethi S, Raman DS, Behera D. Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital. Mycoses 2002; 45: 295-299.
92. Akiyama K, Takizawa H, Suzuki M, et al. Allergic bronchopulmonary aspergillosis due to Aspergillus oryzae. Chest 1987; 91 285-286.
93. Pasqualotto AC, Denning DW. An aspergilloma caused by Aspergillus flavus. Med Mycol 2008; 46: 275-278.
94. Correa ME, Soares AB, de Souza CA, et al. Primary aspergillosis affecting the tongue of a leukemic patient. Oral Dis 2003; 9 49-53.
95. Bor O, Cagri Dinleyici E, Kiraz N, Dundar E, Akdeniz Akgun N. Successful treatment of tongue aspergillosis caused by Aspergillus flavus with liposomal amphotericin B in a child with acute lymphoblastic leukemia. Med Mycol 2006; 44: 767-770.
96. Pasqualotto AC, Denning DW. Post-operative aspergillosis. Clin Microbiol Infect 2006; 12: 1060-1076.
97. De Vuyst D, Surmont I, Verhaegen J, Vanhaecke J. Tibial osteomyelitis due to Aspergillus flavus in a heart transplant patient. Infection 1992; 20: 48-49.
98. Corrall CJ, Merz WG, Rekedal K, Hughes WT. Aspergillus osteomyelitis in an immunocompetent adolescent: A case report and review of the literature. Pediatrics 1982; 70: 455-461.
99. Cimerman M, Gunde-Cimerman N, Zalar P, Perkovic T. Femur osteomyelitis due to a mixed fungal infection in a previously healthy man. J Clin Microbiol 1999; 37: 1532-1535.
100. Vonberg RP, Gastmeier P. Nosocomial aspergillosis in outbreak settings. J Hosp Infect 2006; 63: 246-254.